Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | ABVX | ARWR | ||
| Company | Verona Pharma Plc ADR | Abivax Sa ADR | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 109.75 | 62.95 | ||
| High | 106.93 | 115.12 | 64.28 | ||
| Low | 106.81 | 109.10 | 60.29 | ||
| Latest | 106.91 | 114.51 | 61.44 | ||
| Change | +0.12 | +3.87 | -3.22 | ||
| % Change | +0.11% | +3.50% | -4.98% | ||
| Volume | 1,871,900 | 1,297,100 | 3,588,000 | ||
| 20-Day Average Volume | 1,504,320 | 1,415,910 | 2,907,200 | ||
| Previous Close | 106.79 | 110.64 | 64.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 114.64 | 47.47 | ||
| 20-Day Raw Stochastic | 98.26% | 47.09% | 81.05% | ||
| 20-Day Relative Strength | 70.52 | 57.05 | 70.28 | ||
| Weighted Alpha | +201.62 | +159.84 | +209.68 | ||
| Today's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | -8.27% since 11/28/25 | +16.58% since 11/28/25 | ||
| Low | 106.61 on 09/30/25 | 107.06 on 12/04/25 | 52.23 on 12/01/25 | ||
| High | 106.93 on 10/06/25 | 125.51 on 12/01/25 | 67.14 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +14.96% since 11/05/25 | +52.42% since 11/05/25 | ||
| Low | 105.78 on 09/19/25 | 100.50 on 11/13/25 | 37.06 on 11/20/25 | ||
| High | 106.93 on 10/06/25 | 130.25 on 11/26/25 | 67.14 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +30.08% since 09/05/25 | +111.32% since 09/05/25 | ||
| Low | 86.63 on 07/08/25 | 80.11 on 09/18/25 | 27.10 on 09/08/25 | ||
| High | 106.93 on 10/06/25 | 130.25 on 11/26/25 | 67.14 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +1,305.03% since 06/05/25 | +273.27% since 06/05/25 | ||
| Low | 47.20 on 04/07/25 | 5.69 on 06/23/25 | 14.30 on 07/22/25 | ||
| High | 106.93 on 10/06/25 | 130.25 on 11/26/25 | 67.14 on 12/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,912,199 | 8,344,166 | ||
| Shares Outstanding, K | 81,830 | 77,829 | 135,810 | ||
| Annual Sales | 42,280,000 | 0 | 829,450,000 | ||
| Annual Net Income | -173,420,000 | -190,710,000 | -1,630,000 | ||
| Last Quarter Sales | 103,140,000 | 0 | 256,470,000 | ||
| Last Quarter Net Income | 11,920,000 | -54,960,000 | -23,750,000 | ||
| 60-Month Beta | 0.05 | 0.48 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | -0.86 on 09/08/25 | -0.18 on 11/25/25 | ||
| Latest Earnings Date | 11/03/25 | 08/11/25 | 11/25/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||